Latest filing published 13 Jul 2023 for Enfusion, Inc., €9.7M.
Filing timeline
BuySaleInsider track record
Tarek Hammoud: trading record in brief
Tarek Hammoud discloses dealings in Enfusion, Inc. to SEC (Form 4). Over a trading history stretching from 17 October 2022 to 11 July 2023, the count stands at 7 filings.
Sales make up the whole of the open-market record (4 sales, €40.9M). So far in 2023, the count stands at no purchases and 3 sales.
The record was last updated on 13 July 2023 with an open-market sale (€9.7M) in Enfusion, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tarek Hammoud
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 shares@ US$10.7030.4% of flowClass A Common StockSEC:0000899243-23-017386:0
- 1,000,000 sharesClass A Common StockSEC:0000899243-23-009789:0
- 1,000,000 shares@ US$10.9232.4% of flowClass A Common StockSEC:0000899243-23-008064:0
- 1,870,386 sharesClass A Common StockSEC:0000899243-22-036546:0
- 1,000,000 shares@ US$12.1537.3% of flowClass A Common StockSEC:0000899243-22-035898:0
- 1,000,000 sharesClass A Common StockSEC:0000899243-22-033846:0
6 of 6 declarations